Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-02-13A Phase II Study Of Amifostine In Children With Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2014-02-11Proteases in Prostate Cancer Bone Metastasis
-
CLINICAL_TRIALS study record update · 2014-02-11AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2014-02-11Phase II Trial of Sorafenib in Patients With Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2014-02-03The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-01-10The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells
-
CLINICAL_TRIALS study record update · 2014-01-08Preemptive CD8+ T-cell Depleted Donor Lymphocyte Infusion (DLI) Following Nonmyeloablative Stem Cell Transplantation (NMT) for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2014-01-06Phase 2 Study of Proteinase 3 PR1 Peptide Mixed With Montanide ISA 51 VG Adjuvant and Administered With GM-CSF in Low Risk and Intermediate-1 MDS
-
CLINICAL_TRIALS study record update · 2014-01-06Non-myeloablative Allogeneic Stem Cell Transplantation With Match Unrelated Donors for Treatment of Hematologic Malignancies and Renal Cell Carcinoma and Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2014-01-06Non-Ablative Chemotherapeutic Conditioning Before Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-12-19A Randomized Study Of The Safety And Efficacy Of Two Dose Schedules Of Gemcituzumab Ozogamicin In Patients With Intermediate-2 Or High-Risk Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2013-12-19Phase I Trial of High Dose Chemotherapy Using Amifostine for In-Vivo Protection of GM-CSF Primed Progenitor Cells
-
CLINICAL_TRIALS study record update · 2013-12-19Protocol for Patients With High Risk (Resistant, Refractory, Relapsed or Adverse Cytogenetic) AML
-
CLINICAL_TRIALS study record update · 2013-12-18Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-12-18Transplantation Using Umbilical Cord And Placental Blood
-
CLINICAL_TRIALS study record update · 2013-12-18A Randomized Trial for Patients With Acute Myeloid Leukemia or High Risk Myelodysplatic Syndrome Aged 60 or Over
-
CLINICAL_TRIALS study record update · 2013-12-18A Phase I Study of a Combination of 5-azacitidine Followed by Lenalidomide in High-risk MDS or Relapsed/Refractory AML Patients With Cytogenetic Abnormalities Including -5 or Del(5q)
-
CLINICAL_TRIALS study record update · 2013-12-17A Multicenter, Single-arm Study to Assess the Safety, Pharmacokinetics and Efficacy of Lenalidomide in Japanese Subjects With Low- or Intern=Mediate-1-risk Myelodysplastic Syndromes (MDS) Associated With a Deletion 5 (q31-33) Abnormality and Symptomatic Anemia
-
CLINICAL_TRIALS study record update · 2013-12-13A Pilot Phase II Study of Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-12-06Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2013-12-04Treatment of Poor Risk Myelodysplasia With the Combination of Amifostine, Topotecan and ARA-C: A Phase II Study
-
CLINICAL_TRIALS study record update · 2013-12-04Medical Research Council Working Party on Leukaemia in Childhood Acute Myeloid Leukaemia Trial 12
-
CLINICAL_TRIALS study record update · 2013-11-26Phase II Study of 5-azacytidine and Lintuzumab in Myelodysplastic Syndromes (MDS)
-
CLINICAL_TRIALS study record update · 2013-11-08SHP2 as a Therapeutic Target For Myelodysplastic Syndrome: Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2013-11-07A Randomized, MultiCenter, Open-Label, Modified Dose-Ascension, Parallel Study of the Safety, Tolerability, and Efficacy of Oral SCIO-469 in Patients With Myelodysplastic Syndromes